arginine Archives - Sanford Burnham Prebys
Institute News

Fine-tuning cellular energy increases longevity

AuthorJessica Moore
Date

February 25, 2016

New research from SBP has identified a protein that can extend the natural lifespan of C. elegans, a microscopic roundworm commonly used for research on aging and longevity. The findings, published in Cell Reports, expand what we know about the aging process and may lead to new ways to delay the onset of human age-related diseases such as cancer and neurodegenerative diseases. Continue reading “Fine-tuning cellular energy increases longevity”

Institute News

New STRIVE awards announced

Authorsgammon
Date

October 8, 2015

“The STRIVE award is providing funds that allow us to accelerate the testing of a new hypothesis that connects the microbiome, epigenetics, and colorectal cancer.”        

          –Alex Strongin, PhD professor in the Bioinformatics and Structural Biology Program at SBP. Continue reading “New STRIVE awards announced”

Institute News

Potential drug targets could improve treatment of vascular disease in diabetic patients

Authorsgammon
Date

July 15, 2015

The newly discovered role of a vascular protein in diabetes-induced hardening of the arteries could lead to better treatments that reduce the risk of heart attack, stroke, and death, according to research spearheaded by SBP investigators. The study, published recently in Circulation Research, reveals that a receptor called LRP6 inhibits molecular signals that drive diet-induced hardening of the arteries, also known as arteriosclerosis. Continue reading “Potential drug targets could improve treatment of vascular disease in diabetic patients”

Institute News

Enzymes could be key for brain cancer and Alzheimer’s disease

AuthorGuest Blogger
Date

December 9, 2014

This post was written by Janelle Weaver, PhD, a freelance writer.

Animals ranging from fish to humans produce a vitamin-A metabolite called retinoic acid, which plays an important role in growth and embryonic development and protects against diseases such as cancer. By regulating the activity of key genes, retinoic acid causes immature cells called embryonic stem cells to turn into mature, specialized cells such as neurons. “Neurons—the building blocks of the nervous system—are particularly important cell types in therapy, due to the fact that they normally don’t reproduce or replace themselves after they become damaged,” said Laszlo Nagy, MD, PhD, director of the Genomic Control of Metabolism Program and professor in the Diabetes and Obesity Research Center at Sanford-Burnham’s Lake Nona campus. “Despite their crucial role, we still have a limited understanding regarding the molecular programs that coordinate their functionality.” Continue reading “Enzymes could be key for brain cancer and Alzheimer’s disease”